Effect of patient-optimized doses of tamsulosin on erectile function in men with erectile dysfunction and lower urinary tract symptoms

about

Effects of tamsulosin on premature ejaculation in men with benign prostatic hyperplasia

P2860

Q34198858-70779ED6-25DD-4F71-9E1F-1E21D141F582

P2860

Effect of patient-optimized doses of tamsulosin on erectile function in men with erectile dysfunction and lower urinary tract symptoms

Item

http://www.wikidata.org/entity/Q41815504

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Effect of patient-optimized do ...... d lower urinary tract symptoms

@en

type

Item

label

Effect of patient-optimized do ...... d lower urinary tract symptoms

@en

prefLabel

Effect of patient-optimized do ...... d lower urinary tract symptoms

@en

P1476

Effect of patient-optimized do ...... d lower urinary tract symptoms

@en

P2093

Dae Kyung Kim

http://www.w3.org/2001/XMLSchema#string

Eun Tak Kim

http://www.w3.org/2001/XMLSchema#string

Ha Wook Whang

http://www.w3.org/2001/XMLSchema#string

Hyun Taek Ju

http://www.w3.org/2001/XMLSchema#string

Hyun Wook Jo

http://www.w3.org/2001/XMLSchema#string

Jinsung Park

http://www.w3.org/2001/XMLSchema#string

Seung Hyo Woo

http://www.w3.org/2001/XMLSchema#string

P2860

The metabolic syndrome

Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.

Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

Impact of medical treatments for benign prostatic hyperplasia on sexual function.

Effects of alpha(1)-adrenoceptor antagonists on male sexual function.

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action.

Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical management.

Combined tadalafil and α-blocker therapy for benign prostatic hyperplasia in patients with erectile dysfunction: a multicenter, prospective study.

Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study.

Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.

P304

100-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4111/KJU.2013.54.2.100

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dae-Seon Yoo

P577

2013-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236101158

http://www.w3.org/2001/XMLSchema#string

P698

23550146

http://www.w3.org/2001/XMLSchema#string

P932

3580298

http://www.w3.org/2001/XMLSchema#string

Effect of patient-optimized doses of tamsulosin on erectile function in men with erectile dysfunction and lower urinary tract symptoms

about

P2860

P2860

Effect of patient-optimized doses of tamsulosin on erectile function in men with erectile dysfunction and lower urinary tract symptoms

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932